Disease burden and projection of total and early-onset colorectal cancer in Gulf cooperation council countries from 1990 to 2019

IF 4.8 2区 医学 Q1 Biochemistry, Genetics and Molecular Biology
Majed Ramadan , Hanin Ghamdi , Doaa Aboalola , Noha Alorainan , Ragad Alsalmi , Ahmed Afash , Albaraa Hariri , Atheer Alboloshi , Alaa Samkari , Rawiah Alsiary
{"title":"Disease burden and projection of total and early-onset colorectal cancer in Gulf cooperation council countries from 1990 to 2019","authors":"Majed Ramadan ,&nbsp;Hanin Ghamdi ,&nbsp;Doaa Aboalola ,&nbsp;Noha Alorainan ,&nbsp;Ragad Alsalmi ,&nbsp;Ahmed Afash ,&nbsp;Albaraa Hariri ,&nbsp;Atheer Alboloshi ,&nbsp;Alaa Samkari ,&nbsp;Rawiah Alsiary","doi":"10.1016/j.neo.2024.100988","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Early-onset colorectal cancer (EO-CRC) incidence and prevalence trends in the rise in high income countries, such as the Gulf Cooperation Council (GCC) countries. The study aimed to offer an up-to-date assessment of the overall burden of CRC, and EO-CRC in GCC countries and project its incidence and mortality in 2030.</p></div><div><h3>Method</h3><p>The prevalence, incidence, mortality, years of life lived with disability (YLDs), and disability-adjusted life years (DALYs) of CRC were obtained from the Global Burden of Disease (GBD) Study 2019. The incidence and mortality of CRC, and EO-CRC up to 2030 were predicted.</p></div><div><h3>Results</h3><p>All GCC countries showed a higher annual average percentage changes (AAPC) AAPC incidence rate for EO-CRC compared to CRC. In Saudi Arabia the number of CRC cases has increased from 1990 1484.57; (95 % UI 1987.98,1083.86) 11.4-fold-increase to 16991.83; (95 % UI 21754.79,12892.12) in 2019. In 2030, the total incidence cases of CRC for the six Gulf countries are expected to reach 13,339 thousand, primarily driven by Saudi Arabia with 7,910.19 cases. In 2030, the CRC mortality rate is projected to be 7,647 cases, with nearly 57 % of CRC mortality cases anticipated in Saudi Arabia.</p></div><div><h3>Conclusion</h3><p>This study sheds light on the alarming rise in CRC and EO-CRC across Gulf countries from 1990 to 2019, emphasizing Saudi Arabia's significant burden. It projects a concerning increase in CRC incidence and mortality by 2030, primarily in Saudi Arabia, and highlights the need for immediate public health interventions.</p></div>","PeriodicalId":18917,"journal":{"name":"Neoplasia","volume":null,"pages":null},"PeriodicalIF":4.8000,"publicationDate":"2024-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1476558624000253/pdfft?md5=2800fbb879f8fa87804346e52180016c&pid=1-s2.0-S1476558624000253-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neoplasia","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1476558624000253","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Early-onset colorectal cancer (EO-CRC) incidence and prevalence trends in the rise in high income countries, such as the Gulf Cooperation Council (GCC) countries. The study aimed to offer an up-to-date assessment of the overall burden of CRC, and EO-CRC in GCC countries and project its incidence and mortality in 2030.

Method

The prevalence, incidence, mortality, years of life lived with disability (YLDs), and disability-adjusted life years (DALYs) of CRC were obtained from the Global Burden of Disease (GBD) Study 2019. The incidence and mortality of CRC, and EO-CRC up to 2030 were predicted.

Results

All GCC countries showed a higher annual average percentage changes (AAPC) AAPC incidence rate for EO-CRC compared to CRC. In Saudi Arabia the number of CRC cases has increased from 1990 1484.57; (95 % UI 1987.98,1083.86) 11.4-fold-increase to 16991.83; (95 % UI 21754.79,12892.12) in 2019. In 2030, the total incidence cases of CRC for the six Gulf countries are expected to reach 13,339 thousand, primarily driven by Saudi Arabia with 7,910.19 cases. In 2030, the CRC mortality rate is projected to be 7,647 cases, with nearly 57 % of CRC mortality cases anticipated in Saudi Arabia.

Conclusion

This study sheds light on the alarming rise in CRC and EO-CRC across Gulf countries from 1990 to 2019, emphasizing Saudi Arabia's significant burden. It projects a concerning increase in CRC incidence and mortality by 2030, primarily in Saudi Arabia, and highlights the need for immediate public health interventions.

1990 年至 2019 年海湾合作委员会国家的疾病负担和总结肠癌与早发结直肠癌预测
背景海湾合作委员会(GCC)国家等高收入国家的早发结直肠癌(EO-CRC)发病率和流行率呈上升趋势。该研究旨在对海湾合作委员会国家的 CRC 和 EO-CRC 总体负担进行最新评估,并预测 2030 年的发病率和死亡率。方法从《2019 年全球疾病负担(GBD)研究》中获取 CRC 的患病率、发病率、死亡率、残疾生活年数(YLDs)和残疾调整生活年数(DALYs)。结果所有海湾合作委员会国家的 EO-CRC 年平均百分比变化(AAPC)均高于 CRC。在沙特阿拉伯,CRC 病例数从 1990 年的 1484.57;(95 % UI 1987.98,1083.86)增长 11.4 倍至 2019 年的 16991.83;(95 % UI 21754.79,12892.12)。2030 年,海湾六国的 CRC 总发病例数预计将达到 1333.9 万例,主要是沙特阿拉伯的 7910.19 例。2030 年,CRC 死亡率预计为 7647 例,其中近 57% 的 CRC 死亡病例预计发生在沙特阿拉伯。研究预测,到 2030 年,主要是沙特阿拉伯的 CRC 发病率和死亡率将出现令人担忧的增长,并强调了立即采取公共卫生干预措施的必要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Neoplasia
Neoplasia 医学-肿瘤学
CiteScore
9.20
自引率
2.10%
发文量
82
审稿时长
26 days
期刊介绍: Neoplasia publishes the results of novel investigations in all areas of oncology research. The title Neoplasia was chosen to convey the journal’s breadth, which encompasses the traditional disciplines of cancer research as well as emerging fields and interdisciplinary investigations. Neoplasia is interested in studies describing new molecular and genetic findings relating to the neoplastic phenotype and in laboratory and clinical studies demonstrating creative applications of advances in the basic sciences to risk assessment, prognostic indications, detection, diagnosis, and treatment. In addition to regular Research Reports, Neoplasia also publishes Reviews and Meeting Reports. Neoplasia is committed to ensuring a thorough, fair, and rapid review and publication schedule to further its mission of serving both the scientific and clinical communities by disseminating important data and ideas in cancer research.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信